EverSource Wealth Advisors LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 37.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,092 shares of the exchange traded fund’s stock after selling 10,626 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $2,311,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Financial Life Planners purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth $27,000. Intesa Sanpaolo Wealth Management acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth $30,000. SHP Wealth Management purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $31,000. Finally, Legacy Wealth Managment LLC ID purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $32,000.
SPDR S&P Biotech ETF Trading Down 1.2%
NYSEARCA:XBI opened at $147.91 on Thursday. The company’s 50-day moving average price is $145.48 and its 200-day moving average price is $134.07. The company has a market cap of $9.73 billion, a P/E ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a twelve month low of $84.39 and a twelve month high of $165.71.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
